Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

STATUS

Recruiting
End date

Feb 28, 2027
participants needed

1174
sponsor

H. Lee Moffitt Cancer Center and Research Institute

Send

Updated on 19 February 2024

See if I qualify

cancer

endoscopy

cyst

pancreatitis

intraductal papillary mucinous neoplasms of the pancreas

ipmn

Summary

Show definitions

The Florida Pancreas Collaborative wants to partner with individuals who are known to have, or are suspected to have a pancreatic lesion, tumor, cyst, mass, cancer, or pancreatitis and are undergoing diagnosis and treatment at a participating institution. The goals of this project are to build a large database of information obtained from blood, tissue, medical images, surveys and information from routine care to develop noninvasive diagnostic approaches that could be used as decision-making tools to effectively personalize clinical care.

Details

Condition	Pancreatic Cancer, Pancreatic Cancer, Pancreatic disorder, Pancreatic Cyst, Neoplasm of unspecified nature of digestive system
Age	18years - 100years
Treatment	data collection, Blood Sample collection, Tissue sample collection
Clinical Study Identifier	NCT04275557
Sponsor	H. Lee Moffitt Cancer Center and Research Institute
Last Modified on	19 February 2024

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	Individuals who present to the GI clinic, surgery, or endoscopy at Moffitt, UF, or UM with a clinical suspicion for (or diagnosis of) a pancreatic lesion, cyst, mass, cancer, or pancreatitis based on symptoms, imaging, or blood-work and has not had any treatment involving their pancreas
	Able to understand and voluntarily sign the informed consent
	Willing to complete study questionnaire(s) and donate medical images and biological specimens (including blood, cystic fluid, and tissue) obtained at the time of standard of care procedures (biopsy, surgery, and venipuncture) after signing the informed consent document
Exclusion Criteria
	No suspicion or diagnosis of a pancreatic lesion, cyst, mass, cancer, or pancreatitis
	Has a diagnosis of a pancreatic lesion, cyst, mass, cancer, or pancreatitis and has already undergone treatment involving the pancreas (which may involve surgery, chemoor immuno-therapy, and/or radiation)
	Unable to provide informed consent
	Unwilling to complete study questionnaire(s) and/or donate biological specimens or images

How to participate?

Step 1 Connect with a study center

Send a message

Enter your contact details to connect with study team

First name*

Last name*

Email*

Phone number*

Other language

I am at least 18 years old.

By sending a message, I agree to share my information with the study team for the selected site and consent to receive emails and text messages for trial updates, notifications, and related communication. TrialX values your privacy; your information will be handled in accordance with our Privacy Policy

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

intraductal papillary mucinous neoplasms of the pancreas

ipmn

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas